Le Lézard
Classified in: Health, Science and technology
Subject: PER

Astellas Appoints Anthony Fiordaliso to Vice President, Americas Finance


NORTHBROOK, Ill., Dec. 13, 2017 /PRNewswire/ -- Astellas today announced Anthony Fiordaliso, M.B.A., C.P.A., has been promoted to vice president, Americas Finance, reporting to Stephen Knowles, senior vice president, Finance and Information Technology. 

Anthony Fiordaliso has been promoted to vice president, Americas Finance at Astellas.

"Since joining Astellas in March 2010, Tony has held positions of increasing responsibility and has made significant contributions to our Finance organization in the Americas," said Knowles. "Tony's depth and breadth of knowledge and experience in finance related to the pharmaceutical industry position him well for his new role."

In his new position, Fiordaliso will oversee managerial reporting and budgeting, financial planning and analysis, revenue forecasting and recognition, collaboration finance and expense management for Astellas Americas, which includes United States, Canada, Brazil, Colombia and the rest of Latin America.

Previously, Fiordaliso served as executive director, Commercial Finance. Prior to joining Astellas, Fiordaliso held operations and finance positions of increasing responsibility culminating in the role of director, U.S. Financial Operations, at Schering-Plough, now Merck.  Before Schering-Plough, he served as senior internal auditor at Warner-Lambert, now Pfizer. Fiordaliso began his career at Ernst & Young, now EY, as staff auditor performing financial audits of hospitals and healthcare related entities.

Fiordaliso holds a Master of Business Administration from New York University Stern School of Business, as well as a Bachelor of Science degree in accounting from Rutgers University. He achieved licensure as a certified public accountant in the State of New Jersey in 1998.

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at http://www.astellas.us/. You can also follow us on Twitter at @AstellasUS, Facebook at http://www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.

 

Astellas is a pharmaceutical company dedicated to improving the health of people around the world. (PRNewsFoto/Astellas Pharma Inc.)

SOURCE Astellas


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: